Heart surgery upgrade: zap away bad rhythms while implanting pump

NCT ID NCT05034432

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study tests whether destroying small areas of heart muscle that cause dangerous rhythms (ventricular tachycardia ablation) during LVAD implant surgery can reduce the number of these rhythms after surgery. About 100 adults with advanced heart failure who are getting an LVAD will be randomly assigned to either receive the ablation during surgery or standard care. The main goal is to see if the ablation lowers the total number of dangerous heart rhythm events.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Intra-operative ventricular tachycardia ablation (a procedure to destroy small areas of heart muscle that cause abnormal rhythms)
What this could lead to
If it works, this could reduce dangerous heart rhythms after LVAD surgery, potentially lowering hospitalizations and improving recovery.
What could go wrong
This is a phase 4 trial with only 100 participants, so results may not apply to everyone. The ablation itself carries risks like bleeding or damage to the heart.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ascension St. Vincent Indianapolis

    RECRUITING

    Indianapolis, Indiana, 46260, United States

  • Banner University Medical Center

    RECRUITING

    Phoenix, Arizona, 85006, United States

  • Cleveland Clinic

    RECRUITING

    Cleveland, Ohio, 44195, United States

  • Columbia University Medical Center

    RECRUITING

    New York, New York, 10026, United States

  • Emory University

    RECRUITING

    Atlanta, Georgia, 30322, United States

  • Henry Ford Health

    RECRUITING

    Detroit, Michigan, 48202, United States

  • Houston Methodist Hospital

    RECRUITING

    Houston, Texas, 77030, United States

  • Johns Hopkins University

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Medstar Washington Hospital Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Piedmont Heart Institute

    RECRUITING

    Atlanta, Georgia, 30309, United States

  • Tufts Medical Center

    RECRUITING

    Boston, Massachusetts, 02111, United States

  • UCLA Cardiac Arrthmia Center

    RECRUITING

    Los Angeles, California, 90095, United States

  • UPMC

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

  • Univedrsity of Louisville

    RECRUITING

    Louisville, Kentucky, 40202, United States

  • University of California San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • University of Rochester

    RECRUITING

    Rochester, New York, 14642, United States

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.